Εμφανίζονται 1 - 20 Αποτελέσματα από 99 για την αναζήτηση '"специализированные продукты"', χρόνος αναζήτησης: 1,03δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
    Academic Journal

    Πηγή: Meditsinskiy sovet = Medical Council; № 22 (2023); 110-120 ; Медицинский Совет; № 22 (2023); 110-120 ; 2658-5790 ; 2079-701X

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/7998/7087; Durán Poveda M, Suárez-de-la-Rica A, Cancer Minchot E, Ocón Bretón J, Sánchez Pernaute A, Rodríguez Caravaca G. The Prevalence and Impact of Nutritional Risk and Malnutrition in Gastrointestinal Surgical Oncology Patients: A Prospective, Observational, Multicenter, and Exploratory Study. Nutrients. 2023;15(14):3283. https://doi.org/10.3390/nu15143283.; Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48. https://doi.org/10.1016/j.clnu.2016.07.015.; Baldwin C, Spiro A, Ahern R, Emery PW. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2012;104(5):371–385. https://doi.org/10.1093/jnci/djr556.; Ravasco P, Monteiro-Grillo I, Camilo M. Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr. 2012;96(6):1346–1353. https://doi.org/10.3945/ajcn.111.018838.; Baracos VE. Cancer-associated malnutrition. Eur J Clin Nutr. 2018;72(9):1255–1259. https://doi.org/10.1038/s41430-018-0245-4.; Guenter P, Abdelhadi R, Anthony P, Blackmer A, Malone A, Mirtallo JM et al. Malnutrition diagnoses and associated outcomes in hospitalized patients: United States, 2018. Nutr Clin Pract. 2021;36(5):957–969. https://doi.org/10.1002/ncp.10771.; Brown T, Edwards A, Pashley A, Lehn B, Vasani S, Hodge R, Bauer J. Nutritional status and post-operative complications in patients undergoing surgery for advanced pharyngeal or laryngeal cancer. Eur Arch Otorhinolaryngol. 2023;280(12):5531–5538. https://doi.org/10.1007/s00405-023-08139-x.; Shpata V, Prendushi X, Kreka M, Kola I, Kurti F, Ohri I. Malnutrition at the time of surgery affects negatively the clinical outcome of critically ill patients with gastrointestinal cancer. Med Arch. 2014;68(4):263–267. https://doi.org/10.5455/medarh.2014.68.263-267.; Bossi P, Delrio P, Mascheroni A, Zanetti M. The Spectrum of Malnutrition/ Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review. Nutrients. 2021;13(6):1980. https://doi.org/10.3390/nu13061980.; Хомяков ВМ, Хороненко ВЭ, Ермошина АД. Проблема нутритивной недостаточности и методы ее коррекции у больных со злокачественными опухолями пищевода и желудка. Онкология. Журнал им. П.А. Герцена. 2016;5(5):33–37. https://doi.org/10.17116/onkolog20165533-37.; Снеговой АВ, Бесова НС, Веселов АВ, Кравцов СА, Ларионова ВБ, Сельчук ВЮ и др. Практические рекомендации по нутритивной поддержке у онкологических больных. Злокачественные опухоли. 2016;(4s2):434–450. Режим доступа: https://rosoncoweb.ru/standarts/RUSSCO/2016/40.pdf.; Jie B, Jiang ZM, Nolan MT, Zhu SN, Yu K, Kondrup J. Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk. Nutrition. 2012;28(10):1022–1027. https://doi.org/10.1016/j.nut.2012.01.017.; Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T et al. GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1–9. https://doi.org/10.1016/j.clnu.2018.08.002.; Лейдерман ИН, Грицан АИ, Заболотских ИБ, Ломидзе СВ, Мазурок ВА, Нехаев ИВ и др. Периоперационная нутритивная поддержка. Клинические рекомендации. Вестник интенсивной терапии имени А.И. Салтанова. 2018;(3):5–21. https://doi.org/10.21320/1818-474X-2018-3-5-21.; Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr. 2017;36(3):623–650. https://doi.org/10.1016/j.clnu.2017.02.013.; Mortensen K, Nilsson M, Slim K, Schäfer M, Mariette C, Braga M et al. Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Br J Surg. 2014;101(10):1209–1229. https://doi.org/10.1002/bjs.9582.; Li Z, Bai B, Zhao Y, Yu D, Lian B, Liu Y, Zhao Q. Severity of complications and long-term survival after laparoscopic total gastrectomy with D2 lymph node dissection for advanced gastric cancer: A propensity score-matched, case-control study. Int J Surg. 2018;54(Pt A):62–69. https://doi.org/10.1016/j.ijsu.2018.04.034.; Самсонов МА, Покровский АА (ред.). Справочник по диетологии. 2-е изд. М.: Медицина; 1992. 464 с.; Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–495. https://doi.org/10.1016/S1470-2045(10)70218-7.; Wang LH, Zhu RF, Gao C, Wang SL, Shen LZ. Application of enhanced recovery after gastric cancer surgery: An updated meta-analysis. World J Gastroenterol. 2018;24(14):1562–1578. https://doi.org/10.3748/wjg.v24.i14.1562.; Obukhova O, Kashiya S, Kurmukov I. MON-P100: Metabolic Disorders in Patients with Advanced Gastric Cancer before Antitumor Chemotherapy. Clin Nutr. 2017;36(Suppl. 1):S216. https://doi.org/10.1016/S0261-5614(17)30983-4.; Тер-Ованесов МД, Кукош МЮ, Габоян АС, Левицкий АВ, Зраибиа А. Концепция ускоренной реабилитации в хирургическом лечении рака пищевода и желудка: постановка проблемы. Медицинский алфавит. 2017;1(16):17–22. Режим доступа: https://www.med-alphabet.com/jour/article/view/147.; Cantwell LA, Fahy E, Walters ER, Patterson JM. Nutritional prehabilitation in head and neck cancer: a systematic review. Support Care Cancer. 2022;30(11):8831–8843. https://doi.org/10.1007/s00520-022-07239-4.; Горбунова ЕА, Филькин ГН, Медведева НН, Зуков РА. Влияние энтерального питания на клиническое течение послеоперационного периода у больных раком желудка. Эффективная фармакотерапия. 2021;17(2):30–36. Режим доступа: https://umedp.ru/articles/vliyanie_enteralnogo_pitaniya_na_klinicheskoe_techenie_posleoperatsionnogo_perioda_u_bolnykh_rakom_zh.html.; West MA, Wischmeyer PE, Grocott MPW. Prehabilitation and Nutritional Support to Improve Perioperative Outcomes. Curr Anesthesiol Rep. 2017;7(4):340–349. https://doi.org/10.1007/s40140-017-0245-2.

  3. 3
  4. 4
  5. 5
    Academic Journal

    Πηγή: Medical Genetics; Том 21, № 5 (2022); 18-29 ; Медицинская генетика; Том 21, № 5 (2022); 18-29 ; 2073-7998

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.medgen-journal.ru/jour/article/view/2178/1645; Михайлова С. В., Захарова Е. Ю., Петрухин А. С. Нейрометаболические заболевания у детей и подростков: диагностика и подходы к лечению / 2-е изд., перераб. и доп. М. : Литтерра, 2017. 368 с.; Ellaway C.J., Holme E., Standing S., Preece M.A., Green A., Ploechl E., Ugarte M., Trefz F.K., Leonard J.V. Outcome of tyrosinaemia type III. J. Inherit. Metab. Dis. 2001; 24: 824-832.; Delaet C., Dionisi C., Leonard J.V., McKiernan P.J., Mitchell G.A., Monti L., de Baulny H.O., Pintos-Morell G., Spiekerkoetter U. Recommendations for the management of tyrosinaemia type 1. Orphanet J. Rare Dis. 2013; 8: 8.; Van Ginkel W.G., Jahja R., Huijbregts S., van Spronsen F.J. Neurological and neuropsychological problems in tyrosinemia type I patients. In Hereditary Tyrosinemia: Pathogenesis, Screening and Management. Advances in Experimental Medicine and Biology; Springer Science and Business Media LLC: Cham, Switzerland, 2017; 959: 111-122.; Hanley W.B., Linsao L., Davidson W., Moes C.A.F. Malnutrition with early treatment of Phenylketonuria. Pediatr. Res. 1970; 4: 318-327.; Ashorn M., Pitkänen S., Salo M., Heikinheimo M. Current strategies for the treatment of hereditary tyrosinemia type I. Pediatr. Drugs. 2006; 8: 47-54.; McKiernan P.J., Preece M.A., Chakrapani A. Outcome of children with hereditary tyrosinaemia following newborn screening. Arch. Dis. Child. 2015; 100: 738-741.; Van Spronsen F.J., van Rijn M., Meyer U., Das A. Dietary Considerations in Tyrosinemia Type I. In Hereditary Tyrosinemia: Pathogenesis, Screening and Management. Advances in Experimental Medicine and Biology; Springer Science and Business Media LLC: Cham, Switzerland, 2017; 959: 197-204.; Nutritics, R. Edition (v5. 09) [Computer Software]. Available online: https://www.nutritics.com/p/home (accessed on 26 August 2019).; Van Vliet D., Derks T., van Rijn M., de Groot M.J., Macdonald A., Heiner-Fokkema M., van Spronsen F.J. Single amino acid supplementation in aminoacidopathies: A systematic review. Orphanet J. Rare Dis. 2014; 9: 7.; García M.I., de la Parra A., Arias C., Arredondo M., Cabello J.F. Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet. Mol. Genet. Metab. Rep. 2017; 11: 12-16.; Dixon M., Macdonald A., White F., Stafford J. Disorders of amino acid metabolism, organic acidaemias and urea cycle disorders. In Clinical Paediatric Dietetics; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2015:381-525; The Scientific Advisory Committee on Nutrition. Dietary Reference Values for Energy; SACN: London, UK, 2011; Crone M., van Spronsen F.J., Oudshoorn K., Bekhof J., Van Rijn G., Verkerk P.H. Behavioural factors related to metabolic control in patients with phenylketonuria. J. Inherit. Metab. Dis. 2005; 28: 627-637.; MacLeod E.L., Gleason S.T., van Calcar S.C., Ney, D.M. Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes. Mol. Genet. Metab. 2009; 98: 331-337.; Van Spronsen F. J., Thomasse Y., Smit G. P. A., Leonard J. V., Clayton P. T., Fidler V., Heymans H. S. Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment. Hepatology, 1994; 20(5): 1187-1191.; Chinsky J. M., Singh R., Ficicioglu C., Van Karnebeek C. D., et al. Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations. Genetics in Medicine. 2017; 19(12): 1380-1380.; Couce M.L., Dalmau J., Del Toro M., Pintos-Morell G., Aldámiz-Echevarría L., Spanish Working Group on Tyrosinemia type1. Tyrosinemia type 1 in Spain: Mutational analysis, treatment and long-term outcome. Pediatr.Int. 2011; 53: 985-989.; Van Ginkel W., van Vliet D., van der Goot E., van Faassen M., Vogel A., Heiner-Fokkema M., van der Zee E.A., van Spronsen F.J. Blood and brain biochemistry and behaviour in ntbc and dietary treated tyrosinemia type 1 Mice. Nutrients 2019; 11: 2486.; Barone H., Bliksrud Y.T., Elgen I.B., Szigetvari P.D., Kleppe R., Ghorbani S., Hansen E.V., Haavik J. Tyrosinemia Type 1 and symptoms of ADHD: Biochemical mechanisms and implications for treatment and prognosis. Am. J. Med. Genet. Part. B Neuropsychiatr. Genet. 2019; 183: 95-105.; Ассоциация медицинских генетиков, Союз педиатров России, Национальная ассоциация детских реабилитологов. Клинические рекомендации. Тирозинемия, тип 1. Доступно по: https://cr.minzdrav.gov.ru/recomend/409_2; Mayorandan S., Meyer U., Gökçay G., Segarra N.G., de Baulny H.O., van Spronsen, F.J., Zeman J., Delaet C., Spiekerkoetter U., Thimm E., et al. Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice. Orphanet J. Rare Dis. 2014; 9:107.; Dixon M., Macdonald A., White F., Stafford J. Disorders of amino acid metabolism, organic acidaemias and urea cycle disorders. In Clinical Paediatric Dietetics; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2015: 381-525; Daly A., Gokmen-Ozel H., Macdonald A., Preece M.A., Davies P., Chakrapani A., McKiernan P. Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: Should we be concerned? J. Hum. Nutr. Diet. 2011; 25: 111-116.; Smith I., Beasley M.G., E Ades A.Intelligence and quality of dietary treatment in phenylketonuria. Arch. Dis. Child. 1990; 65: 472-478.; Bendadi F., de Koning T.J., Visser G., Prinsen H.C., de Sain M.G., Verhoeven-Duif N., Sinnema G., van Spronsen F.J., van Hasselt P.M. Impaired cognitive functioning in patients with tyrosinemia type I receiving nitisinone. J. Pediatr. 2014; 164: 398-401.; Pinto A., Almeida M., Macdonald A., Ramos P.C., Rocha J.C., Guimas A., Ribeiro R., Martins E., Bandeira A., Jackson R., et al. Over restriction of dietary protein allowance: The importance of ongoing reassessment of natural protein tolerance in Phenylketonuria. Nutrients 2019; 11: 995; Cohn R.M., Yudkoff M., Yost B., Segal S. Phenylalanine-tyrosine deficiency syndrome as a complication of the management of hereditary tyrosinemia. Am. J. Clin. Nutr. 1977; 30: 209-214.; Wilson C.J., Van Wyk K.G., Leonard J.V., Clayton P.T. Phenylalanine supplementation improves the phenylalanine profile in tyrosinaemia. J. Inherit. Metab. Dis. 2000; 23: 677-683.; LaRochelle J., Álvarez F., Bussières J.-F., Chevalier I., Dallaire L., Dubois J., Faucher F., Fenyves D., Goodyer P., Grenier A., et al. Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec. Mol. Genet. Metab. 2012; 107: 49-54.; Ahring K., Bélanger-Quintana A., Dokoupil K., Ozel H.G., Lammardo A.M., Macdonald A., Motzfeldt K., Nowacka M., Robert M., van Rijn M. Dietary management practices in phenylketonuria across European centres. Clin. Nutr. 2009; 28: 231-236.; Lindstedt S., Holme E., Lock E., Hjalmarson O., Strandvik B. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet. 1992; 340: 813-817.; Walter J., White F., Hall S., Macdonald A., Rylance G., Boneh A., Francis D., Shortland G., Schmidt M., Vail A. How practical are recommendations for dietary control in phenylketonuria? Lancet. 2002; 360: 55-57.; El-Shabrawi M.H., Kamal N.M. Current management options for tyrosinemia. Orphan Drugs: Res. Rev. 2013; 3: 1.; Masurel-Paulet A., Poggi-Bach J., Rolland M.-O., Bernard O., Guffon N., Dobbelaere D., Sarles J., De Baulny H.O., Touati G. NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients. J. Inherit. Metab. Dis. 2008; 31: 81-87.; Rouse B.M. Phenylalanine deficiency syndrome. J. Pediatr. 1966; 69: 246-249.; Van Dam E., Daly A., Venema-Liefaard G., van Rijn M., Derks T., McKiernan P.J., Heiner-Fokkema M.R., Macdonald A., van Spronsen F.J., Baumgartner M.R., et al. What is the best blood sampling time for metabolic control of phenylalanine and tyrosine concentrations in tyrosinemia type 1 patients? In JIMD Reports; Springer Science and Business Media LLC: Berlin/Heidelberg, Germany, 2017;36: 49-57.

  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
    Academic Journal

    Πηγή: Neuromuscular Diseases; Том 11, № 4 (2021); 12-25 ; Нервно-мышечные болезни; Том 11, № 4 (2021); 12-25 ; 2413-0443 ; 2222-8721 ; 10.17650/2222-8721-2021-11-4

    Περιγραφή αρχείου: application/pdf

    Relation: https://nmb.abvpress.ru/jour/article/view/465/306; Стенограмма совещания о совершенствовании медицинской помощи детям. Правительство России. Доступно по: http://government.ru/news/42363/. [Transcript of the meeting on improving medical care for children. Russian Government. Available at: http:// government.ru/news/42363/. (In Russ.)].; Baric I., Wagner L., Feyh P. et al. Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis 1999;22(8):867–81. DOI:10.1023/a:1005683222187.; Morton D.H., Bennett M.J., Seargeant L.E. et al. Glutaric aciduria type I: a common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster County, Pennsylvania. Am J Med Genet 1991;41(1):89–95. DOI:10.1002/ajmg.1320410122.; Haworth J.C., Booth F.A., Chudley A.E. et al. Phenotypic variability in glutaric aciduria type I: Report of fourteen cases in five Canadian Indian kindreds. J Pediatr 1991;118(1):52–8. DOI:10.1016/s0022-3476(05)81843-8.; Sauer S.W., Okun J.G., Fricker G. et al. Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the bloodbrain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 2006;97:899–910. DOI:10.1111/j.1471-4159.2006.03813.x.; Михайлова С.В., Захарова Е.Ю., Бобылова М.Ю. и др. Глутаровая ацидурия тип 1: клиника, диагностика и лечение. Журнал неврологии и психиатрии им. С.С. Корсакова 2007;(10):4–12. [Mikhailova S.V., Zakharova E.Yu., Bobylova M.Yu. et al. Glutaric aciduria type 1: clinical presentations, diagnostics and treatment. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = Neuroscience and Behavioral Physiology 2007;(10):4–12. (In Russ.)].; Михайлова С.В., Захарова Е.Ю., Петрухин А.С. Нейрометаболические заболевания у детей и подростков: диагностика и подходы к лечению. 2-е изд., перераб. и доп. М.: Литтерра, 2017. 368 с. [Mikhailova S.V., Zakharova E.Yu., Petrukhin A.S. Neurometabolic diseases in children and adolescents: diagnosis and treatment approaches. 2nd edn., rev. and add. Moscow: Litterra, 2017. 368 p. (In Russ.)].; Boy N., Garbade S.F., Heringer J. et al. Patterns, evolution, and severity of striatal injury in insidious- versus acute-onset glutaric aciduria type 1. J Inherit Metab Dis 2019;42(1):117–27. DOI:10.1002/jimd.12033.; Sauer S., Opp S., Hoffman G.F. et al. Therapeutic modulation of cerebral l-lysine metabolism in a mouse model for glutaric aciduria type 1. Brain 2011;134:157–70. DOI:10.1093/brain/awq269.; Guerreiro G., Faverzani J., Jacques C.E.D. et al. Oxidative damage in glutaric aciduria type 1 patients and the protective effects of l-carnitine treatment. J Cell Biochem 2018;119(12);10021–32. DOI:10.1002/jcb.27332.; Boy N., Mengler K., Thimm E. et al. Newborn screening: a disease-changing intervention for glutaric aciduria type 1. Ann Neurol 2018;83:970–97. DOI:10.1002/jcb.27332.; Heringer J., Boy S.P.N., Ensenauer R. et al. Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 2010;68:743–52. DOI:10.1002/ana.22095.; Viau K., Ernst S.L., Vanzo R.J. et al. Glutaric acidemia type 1: Outcomes before and after expanded newborn screening. Mol Genet Metab 2012;106:430–8. DOI:10.1016/j.ymgme.2012.05.024.; Beauchamp M.H., Boneh A., Anderson V. Cognitive, behavioral and adaptive profiles of children with glutaric aciduria type 1 detected through newborn screening. J Inherit Metab Dis 2009;32(1):207–13. DOI:10.1007/s10545-009-1167-z.; Kölker S., Christensen E., Leonard J.V. et al. Diagnosis and management of glutaric aciduria type I – revised recommendations. J Inherit Metab Dis 2011;34:677–94. DOI:10.1007/s10545-011-9289-5.; Boy N., Mühlhausen C., Maier E.M. et al. Additional individual contributors, proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: Second revision. J Inherit Metab Dis 2017;40:75–101. DOI:10.1007/s10545-016-9999-9.; Kölker S., Christensen E., Leonard J.V., et al. Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherit Metab Dis 2007;30:5–22. DOI:10.1007/s10545-006-0451-4.; Ассоциация медицинских генетиков, Союз педиатров России, Национальная ассоциация детских реабилитологов. Клинические рекомендации. Глутаровая ацидурия, тип 1. Доступно по: https://cr.minzdrav.gov.ru/schema/406_2. [Association of Medical Geneticists, Union of Pediatricians of Russia, National Association of Pediatric Rehabilitation Therapists. Clinical guidelines. Glutaric aciduria, type 1. Available at: https://cr.minzdrav.gov.ru/schema/406_2. (In Russ.)].; Bernstein L., Coughlin C.R., Drumm M. et al. Inconsistencies in the nutrition management of glutaric aciduria type 1: An international survey. Nutrients 2020;12(10):3162. DOI:10.3390/nu12103162.; Clinical Paediatric Dietetics. Ed. by Vanessa Shaw. 5th edn. Hoboken: Wiley-Blackwell, 2020.; Gokmen-Ozel H., MacDonald A., Daly A. et al. Dietary practices in glutaric aciduria type 1 over 16 years. J Hum Nutr Diet 2012;25(6):514–9. DOI:10.1111/j.1365-277X.2012.01269.x.; https://nmb.abvpress.ru/jour/article/view/465

  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
    Academic Journal

    Πηγή: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 65, № 1 (2020); 100-104 ; Российский вестник перинатологии и педиатрии; Том 65, № 1 (2020); 100-104 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2020-65-1

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.ped-perinatology.ru/jour/article/view/1064/896; Georgieff M.K., Brunette K.E., Tran P.V. Early life nutrition and neural plasticity. Dev Psychopathol 2015; 27(2): 411– 423. DOI:10.1017/S0954579415000061 2. Infant and young child feeding. September 2016. https: www. who.int/nutrition/publications/gs_infant_feeding_text_rus.pdf/ Ссылка активна на 20.12.2019.; Fewtrell M., Bronsky J., Campoy C., Domellöf M., Embleton N., Fidler Mis N. et al. Complementary Feeding: A Position Paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition. J Pediatr Gastroenterol Nutr 2017; 64(1): 119–132. DOI:10.1097/MPG.0000000000001454; Национальная программа оптимизации вскармливания детей первого года жизни в Российской Федерации (4-е изд., перераб. и доп.). М., 2019; 206. [National Program for the Optimization of Feeding of Children of the First Year of Life in the Russian Federation (4th edition, revised and supplemented). Moscow, 2019; 206. (in Russ.)]; Национальная программа оптимизации питания детей в возрасте от 1 года до 3 лет в Российской Федерации (2-е издание, исправленное и дополненное), М.: ПедиатрЪ, 2016; 36. [The National Nutrition Optimization Program for Children aged 1 to 3 years in the Russian Federation (2nd edition, amended and supplemented). Moscow: Pediatr, 2016; 36. (in Russ.)]; Захарова И.Н., Мальцев С.В., Боровик Т.Э., Яцык Г.В., Малявская С.И. и др. Недостаточность витамина D у детей раннего возраста в России: результаты многоцентрового когортного исследования РОDНИЧОК (2013–2014 гг.). Вопросы современной педиатрии 2014; 13(6): 30–34. [Zakharova I.N., Maltsev S.V., Borovik T.E., Yatsyk G.V., Malyavskaya S.I. et al. Vitamin D deficiency in young children in Russia: results of a multicenter cohort study PODNICHOK (2013–2014). Voprosy sovremennoi pediatrii (Current pediatrics) 2014; 13(6): 30–34. (in Russ.)]; Национальная программа «Недостаточность витамина D у детей и подростков РФ: современные подходы к коррекции». М.: ПедиатрЪ, 2018; 96. [National program «Vitamin D deficiency in children and adolescents of the Russian Federation: modern approaches to correction». Moscow: Pediatr, 2018; 96. (in Russ.)]; Мельниченко Г.А., Трошина Е.А., Платонова Н.М., Панфилова Е.А., Рыбакова А.А., Абдулхабирова Ф.М. и др. Йододефицитные заболевания щитовидной железы в Российской Федерации: современное состояние проблемы. Аналитический обзор публикаций и данных официальной государственной статистики (Росстат). Consilium Medicum 2019; 21(4): 14–20. [Melnichenko G.A., Troshina E.A., Platonova N.M., Panfilova E.A., Rybakova A.A., Abdulkhabirova F.M. et al. Iodine deficiency diseases of the thyroid gland in the Russian Federation: current state of the problem. Analytical review of publications and official state statistics (Rosstat). Consilium Medicum 2019; 21 (4): 14–20. (in Russ.)] DOI:10.26442/20751753.2019.4.190337; Национальная программа по оптимизации обеспеченности витаминами и минеральными веществами детей России (и использованию витаминных и витаминноминеральных комплексов и обогащенных продуктов в педиатрической практике). М.: ПедиатрЪ, 2017; 152. [The national program for optimizing the provision of vitamins and minerals for children in Russia (and the use of vitamin and vitamin-mineral complexes and fortified products in pediatric practice). Moscow: Pediatr, 2017; 152. (in Russ.)]; Коденцова В.М., Вржесинская О.А. Витамины в питании беременных и кормящих женщин. Вопросы гинекологии, акушерства и перинатологии 2013; 12(3); 38–50. [Kodentsova V.M., Vrzhesinskaya O.A. Vitamins in the diet of pregnant and lactating women. Voprosy ginekologii akusherstva i perinatologii 2013; 12(3); 38–50 (in Russ.)]; Benninga M.A., Faure C., Hyman P.E., St James Roberts I., Schechter N.L., Nurko S. Childhood Functional Gastrointestinal Disorders: Neonate/Toddler. Gastroenterol 2016; 150(6): 1443–1455. DOI:10.1053/j.gastro.2016.02.016; Zeevenhooven J., Browne P.D., L’Hoir M.B., De Weerth C., Benninga M.A. Infant colic: mechanisms and management. Nat Rev Gastroenterol Hepatol 2018; 15(8): 479–496. DOI:10.1038/s41575-018-0008-7; Kim J.S. Excessive crying: behavioral and emotional regulation disorder in infancy. Korean J Pediatr 2011; 54(6): 229– 233. DOI:10.3345/kjp.2011.54.6.229; Sung V. Infantile colic. Aust Prescr 2018; 41(4): 105–110. DOI:10.18773/austprescr.2018.033; Vandenplas Y. Algorithms for Common Gastrointestinal Disorders. J Pediatr Gastroenterol Nutr 2016; 63(Supp l): S38– 40. DOI:10.1097/MPG.0000000000001220; Global atlas of allergy. EAACI, 2014. https: www.ru.scribd. com›doc/232178695/Global-Atlas-Allergy; Heine R.G. Cow’s-milk allergy and lactose malabsorption in infants with colic. J Pediatr Gastroenterol Nutr 2013; 57: S25–S27.; Savino F., Castagno E., Bretto R., Brondello C., Palumeri E., Oggero R. A prospective 10-year study on children who had severe infantile colic. Acta Paediatr Suppl 2005; 94(449): 129–132. DOI:10.1111/j.1651-2227.2005.tb02169.x; EAACI Food Allergy and Anaphylaxis Guidelines. 2014. https://www.eaaci.org›foodallergyandanaphylaxisguidelines…web…; Турти Т.В., Намазова-Баранова Л.С., Боровик Т.Э., Давыдова И.В., Сновская М.А. Диетологические возможности профилактики атопии у детей в период введения прикорма. Вопросы современной педиатрии 2012; 11(4): 38–46. [Turti T.V., Namazova-Baranova L.S., Borovik T.E., Davydova I.V., Snovskaya M.A. The possibilities of diet prophylaxis of atopy in children at the period of additional feeding introduction. Voprosy sovremennoi pediatrii (Current pediatrics) 2012; 11(4): 38–46. (in Russ.); Feeding Guidelines for Infants and Young Toddlers: A Responsive Parenting Approach, February 2017. https: www. healthyeatingresearch.org/wp-content/uploads/2017/02/ her_feeding_guidelines_report_021416-1.pdf/ Ссылка активна на 20.12.2019.; Намазова-Баранова Л.С., Турти Т.В., Сновская М.А., Лукоянова О.Л., Зимина Е.П., Бакович Е.А. и др. Оценка переносимости и безопасности монокомпонентных продуктов прикорма в питании детей раннего возраста с риском развития аллергических болезней. Вопросы современной педиатрии 2016; 15 (2): 154–160. [Namazova-Baranova L.S., Turti T.V., Snovskaya M.A., Lukoyanova O.L., Zimina Y.P., Bakovich Y.A. et al. Assessment of Tolerability and Safety of Monocomponent Complementary Food Products in the Diet of Infants With Risk for Allergic Diseases. Voprosy sovremennoi pediatrii (Current pediatrics) 2016; 15(2): 154–160. (in Russ.)] DOI:10.15690/vsp. v15i2.1533

  17. 17
    Academic Journal

    Συγγραφείς: Potoroko, I.Yu., Paymulina, A.V., Uskova, D.G.

    Πηγή: Bulletin of the South Ural State University. Series Food and Biotechnology. 4:39-46

    Περιγραφή αρχείου: application/pdf

  18. 18
    Academic Journal
  19. 19
  20. 20